American Trust’s Concentrix CNXC Stock Holding History

American Trust’s Portfolio CNXC Stock Details CNXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,564	Closed	-$212K	–	426
2022 Q2	$212K	Buy	1,564 +120	+8%	+$18.1K	0.02%	409
2022 Q1	$241K	Buy	+1,444	New	+$274K	0.02%	407

Other funds holding CNXC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

American Trust's CNXC Position: Q3 2022 in Review

American Trust sold out of Concentrix (CNXC) in Q3 2022, closing a stake of 1,564 shares — an estimated $212K sold.

American Trust first reported a position in CNXC in Q1 2022 and held it in 2 quarters. The position peaked at $241K in Q1 2022. 311 funds tracked by Wall St. Rank hold CNXC as of Q3 2022.

American Trust reported no remaining Concentrix position as of Q3 2022 after selling out during the quarter.
American Trust sold 1,564 Concentrix shares in Q3 2022, an estimated $212K.
American Trust first reported a position in Concentrix in Q1 2022 and held it in 2 quarters.
American Trust's Concentrix position peaked at $241K in Q1 2022.
311 funds tracked by Wall St. Rank held Concentrix as of Q3 2022.

Based on American Trust's 13F filing for Q3 2022, filed 2 Dec 2022.